Actionable news
0
All posts from Actionable news
Actionable news in RDHL: Redhill Biopharma Ltd.,

RedHill Biopharma: Why Analysts Think Shares Can Double

Summary

This weekend's biotech focus feature is on a small Israeli-based biopharma named RedHill Biopharma.

The company's pipeline continues to develop, and it should have two key Phase 3 readouts by the end of 2016, which could significantly move the stock.

Several analyst firms think the shares can at least double if successful. Our granular analysis on this attractive risk/reward profile is below.

"Always keep your portfolio and your risk at your own individual comfortable sleeping point." - Mario Gabelli

This weekend's deep-dive analysis in on an "off the radar" biopharma company that happens to be based in...


More